StonvexLoading…
StonvexStonvexStonvexCore line items from TALK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $228.87M | $187.59M | $150.04M | $119.57M |
Operating Income | $3.15M | $-4.50M | $-23.21M | $-83.16M |
Net Income | $7.79M | $1.15M | $-19.18M | $-79.67M |
EPS (Diluted) | $0.04 | $0.01 | $-0.12 | $-0.51 |
Total Assets | $134.86M | $138.68M | $142.22M | $156.25M |
Total Liabilities | $17.85M | $21.28M | $23.57M | $28.72M |
Cash & Equivalents | $37.35M | $76.69M | $123.91M | $138.54M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-16.54M | $-61.43M |
Shares Outstanding | 166.72M | 168.85M | 168.43M | 161.16M |